Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
soybean oil emulsion (Fresenius Kabi)
- Development stage
- Unknown
- Lead developer
- Fresenius Kabi
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Small Molecules
- Administration
- Intravenous, Parenteral
01
Overview
Intralipid is a sterile, non-pyrogenic lipid injectable emulsion used for intravenous administration as a source of calories and essential fatty acids. It is composed of soybean oil, egg yolk phospholipids (as an emulsifier), and glycerin (to adjust tonicity). The soybean oil component is a mixture of mainly polyunsaturated long-chain triglycerides, providing essential fatty acids such as linoleic and alpha-linolenic acid. Intralipid is primarily indicated for adult and pediatric patients requiring parenteral nutrition when oral or enteral nutrition is impossible, insufficient, or contraindicated. It is also used to prevent or treat essential fatty acid deficiency (EFAD). The emulsion is designed to mimic the structure and metabolic clearance of endogenous chylomicrons, being cleared from the bloodstream by the enzyme lipoprotein lipase. It was originally developed by Fresenius Kabi and is widely distributed by Baxter Healthcare.
- Brand names
- Intralipid
- Other names
- Intralipidsintravenous fat emulsionIVFEsoybean oil
02
Targets
LPL (Lipoprotein lipase)
Beyond the preview
Go deeper on soybean oil emulsion (Fresenius Kabi).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on soybean oil emulsion (Fresenius Kabi).